APA (7th ed.) Citation

TM, H., A, S., R, Z., H, A., M, B., M, A., . . . GC, F. (2025). Recombinant human pro-urokinase vs. alteplase within 4.5 hours of acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 34(8), 108392. https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108392

Chicago Style (17th ed.) Citation

TM, Hashmi, Shafiq A, Zia R, Ashraf H, Burhan M, Ahmed M, Mesmar A, Ahmed R, and Fonarow GC. "Recombinant Human Pro-urokinase Vs. Alteplase Within 4.5 Hours of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 34, no. 8 (2025): 108392. https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108392.

MLA (9th ed.) Citation

TM, Hashmi, et al. "Recombinant Human Pro-urokinase Vs. Alteplase Within 4.5 Hours of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 34, no. 8, 2025, p. 108392, https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108392.